Neurophysiologic Assessment of Neural Tolerance of a New Paramagnetic Complex

  • N. Corsico
  • P. Tirone
Conference paper


The compound coded B-19036, an octadentate chelate of the paramagnetic ion Gd3+ (3, 6 ,9-triaza-12-oxa-3, 6, 9-tricarboxymethylene -10-carboxy-13-phenyl-tridecanoic acid, gadolinium chelate, Fig. 1), is a new contrast agent for magnetic resonance imaging, developed in our laboratories (Felder et al. 1985). Systemic and neural tolerance for B-19036 was evaluated both after intravenous and intrathecal administration.


Intrathecal Administration Minimal Effective Dose Gadolinium Chelate Paramagnetic Contrast Agent Paramagnetic Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Corsico N, Tirone P (1987) EEG studies in the conscious unrestrained rat: a tool for the study of immediate and delayed neurotoxicity of contrasts media. In: Calabrò A, Leonardi M (eds) Computer Aided Neuroradiology p 255–258Google Scholar
  2. Felder E et al. (1985) Bracco Industria Chimica EP Patent application n. 230893Google Scholar
  3. Irwin S (1968) Comprehensive observational assessement: Ia-A systematic quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13, 222–236PubMedCrossRefGoogle Scholar
  4. Litchfield Jr J T, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Therap 96, 99–113Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • N. Corsico
  • P. Tirone

There are no affiliations available

Personalised recommendations